Jonathan M Hernandez Selected Research

Fibrolamellar hepatocellular carcinoma

6/2020	ASO Author Reflections: Fibrolamellar Hepatocellular Carcinoma and Alpha-Fetoprotein.
6/2020	Elevated Serum α-Fetoprotein is Associated with Abbreviated Survival for Patients with Fibrolamellar Hepatocellular Carcinoma Who Undergo a Curative Resection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan M Hernandez Research Topics

Disease

32	Neoplasms (Cancer) 03/2024 - 09/2011
16	Adenocarcinoma 03/2023 - 02/2009
10	Neoplasm Metastasis (Metastasis) 11/2023 - 09/2011
9	Colorectal Neoplasms (Colorectal Cancer) 04/2023 - 09/2011
7	Stomach Neoplasms (Stomach Cancer) 12/2023 - 12/2017
7	Cholangiocarcinoma 12/2022 - 01/2019
5	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 12/2021
5	Colonic Neoplasms (Colon Cancer) 10/2022 - 09/2011
4	Carcinoma (Carcinomatosis) 03/2023 - 09/2011
4	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2022
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 02/2009
4	Carcinogenesis 01/2019 - 09/2011
3	Adrenocortical Carcinoma 03/2024 - 12/2018
3	Liver Neoplasms (Liver Cancer) 11/2023 - 12/2021
3	Peritoneal Neoplasms 03/2023 - 12/2017
3	Pain (Aches) 02/2012 - 02/2009
2	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2023
2	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2022
2	Gallbladder Neoplasms (Gallbladder Cancer) 01/2022 - 12/2020
2	Margins of Excision 01/2021 - 02/2020
2	Fibrolamellar hepatocellular carcinoma 06/2020 - 06/2020
2	Esophageal Neoplasms (Esophageal Cancer) 06/2018 - 12/2008
2	Rectal Neoplasms (Rectal Cancer) 09/2014 - 06/2013
2	Gastroesophageal Reflux (GERD) 05/2013 - 09/2010
2	Urinary Retention 08/2009 - 02/2009
2	Cicatrix (Scar) 08/2009 - 02/2009
1	Thyroid Neoplasms (Thyroid Cancer) 01/2024
1	Alcoholism (Alcohol Abuse) 10/2023
1	Deglutition Disorders (Dysphagia) 10/2023
1	Bile Reflux 10/2023
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Colitis 01/2023
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2023
1	Hypotension (Low Blood Pressure) 01/2023
1	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2023
1	Ovarian Epithelial Carcinoma 01/2023
1	Merkel Cell Carcinoma 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 04/2023 - 05/2012
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2011
3	Mitotane (Lysodren)FDA Link 03/2024 - 02/2020
3	tremelimumabIBA 01/2023 - 01/2020
3	durvalumabIBA 01/2023 - 01/2020
3	NivolumabIBA 01/2022 - 08/2021
2	Cytotoxins (Cytolysins)IBA 03/2024 - 04/2020
2	DNA (Deoxyribonucleic Acid)IBA 04/2023 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 03/2023 - 01/2023
2	Complement System Proteins (Complement)IBA 01/2023 - 04/2020
2	pembrolizumabIBA 01/2023 - 01/2022
2	LigandsIBA 12/2022 - 08/2015
2	Biomarkers (Surrogate Marker)IBA 12/2022 - 08/2021
2	AntigensIBA 01/2022 - 04/2020
2	IpilimumabIBA 01/2022 - 08/2021
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2019 - 01/2015
1	TAK-243IBA 03/2024
1	Ubiquitin-Activating Enzymes (Ubiquitin-Activating Enzyme)IBA 03/2024
1	venetoclaxIBA 03/2024
1	selpercatinibIBA 01/2024
1	Transcription Factors (Transcription Factor)IBA 11/2023
1	ChromatinIBA 11/2023
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2023
1	Floxuridine (FUdR)FDA LinkGeneric 11/2023
1	MicronutrientsIBA 10/2023
1	Fluorouracil (Carac)FDA LinkGeneric 04/2023
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2023
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Etoposide (VP 16)FDA LinkGeneric 01/2023
1	oregovomabIBA 01/2023
1	ChemokinesIBA 01/2023
1	LeukotrienesIBA 01/2023
1	Small Cytoplasmic RNAIBA 12/2022
1	Cadherins (E-Cadherin)IBA 12/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	osimertinibIBA 01/2022
1	olaparibIBA 01/2022

Therapy/Procedure

16	Therapeutics 12/2023 - 02/2009
11	Drug Therapy (Chemotherapy) 03/2023 - 12/2017
9	Neoadjuvant Therapy 01/2023 - 12/2008
7	Gastrectomy 10/2023 - 12/2017
6	Adjuvant Chemotherapy 10/2022 - 05/2010
5	Radiotherapy 01/2023 - 01/2022
4	Hyperthermic Intraperitoneal Chemotherapy 03/2023 - 12/2018
3	Immunotherapy 01/2023 - 12/2021
3	Cholecystectomy 12/2020 - 02/2009
3	Operative Time 02/2012 - 02/2009
2	Cytoreduction Surgical Procedures 03/2023 - 08/2021
2	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 09/2010
2	Pancreatectomy 11/2012 - 02/2009
1	Liver Transplantation 01/2023
1	Transplantation 01/2023
1	Infusion Pumps (Infusion Pump) 01/2022